INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| May 05, 2004 |
VP Clinical Programs
Trans History: 37
|
VP Clinical Programs | Form 4 | Open market or private sale of non-derivative or derivative security | 20,000 | $13.50 | 12,530 |
| May 05, 2004 |
VP Clinical Programs
Trans History: 37
|
VP Clinical Programs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 20,000 | -- | 15,000 |
| Feb 03, 2014 |
Ten Percent Owner
Trans History: 555
|
Ten Percent Owner | Form 4 | Open market or private purchase of non-derivative or derivative security | 20,023 | $281.14 | 16,034,304 |
| Oct 15, 2014 |
Ten Percent Owner
Trans History: 555
|
Ten Percent Owner | Form 4 | Open market or private purchase of non-derivative or derivative security | 20,062 | $329.79 | 22,518,168 |
| May 01, 2012 |
Director, EVP CSO President Regeneron Re
Trans History: 673
|
Director, EVP CSO President Regeneron Re | Form 4 | Open market or private sale of non-derivative or derivative security | 20,120 | $134.54 | 845,986 |
| Dec 14, 2010 |
VP Controller and Asst Treasur
Trans History: 372
|
VP Controller and Asst Treasur | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 20,180 | -- | 20,180 |
| Dec 24, 2014 |
Ten Percent Owner
Trans History: 555
|
Ten Percent Owner | Form 4 | Open market or private purchase of non-derivative or derivative security | 20,245 | $399.74 | 22,859,144 |
| Mar 28, 2014 |
Ten Percent Owner
Trans History: 555
|
Ten Percent Owner | Form 4 | Open market or private purchase of non-derivative or derivative security | 20,264 | $306.21 | 19,867,509 |
| May 12, 2020 |
Director, President & CEO
Trans History: 427
|
Director, President & CEO | Form 4 | Open market or private sale of non-derivative or derivative security | 20,267 | $570.49 | 528,991 |
| Jun 14, 2017 |
EVP Research and Development
Trans History: 660
|
EVP Research and Development | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 20,295 | $21.25 | 44,245 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.